10-50743009-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001321958.2(ASAH2B):c.-5C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000334 in 1,613,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 0 hom. )
Consequence
ASAH2B
NM_001321958.2 5_prime_UTR_premature_start_codon_gain
NM_001321958.2 5_prime_UTR_premature_start_codon_gain
Scores
1
18
Splicing: ADA: 0.1566
2
Clinical Significance
Conservation
PhyloP100: 0.418
Genes affected
ASAH2B (HGNC:23456): (N-acylsphingosine amidohydrolase 2B) Predicted to enable N-acylsphingosine amidohydrolase activity. Predicted to be involved in ceramide catabolic process; long-chain fatty acid biosynthetic process; and sphingosine biosynthetic process. Predicted to be active in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10947856).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASAH2B | NM_001321958.2 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/6 | ENST00000647317.2 | NP_001308887.1 | ||
ASAH2B | NM_001321958.2 | c.-5C>T | splice_region_variant | 2/6 | ENST00000647317.2 | NP_001308887.1 | ||
ASAH2B | NM_001321958.2 | c.-5C>T | 5_prime_UTR_variant | 2/6 | ENST00000647317.2 | NP_001308887.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASAH2B | ENST00000647317 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/6 | NM_001321958.2 | ENSP00000496089.1 | ||||
ASAH2B | ENST00000647317.2 | c.-5C>T | splice_region_variant | 2/6 | NM_001321958.2 | ENSP00000496089.1 | ||||
ASAH2B | ENST00000647317 | c.-5C>T | 5_prime_UTR_variant | 2/6 | NM_001321958.2 | ENSP00000496089.1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 151714Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
36
AN:
151714
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251488Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135918
GnomAD3 exomes
AF:
AC:
36
AN:
251488
Hom.:
AF XY:
AC XY:
22
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000344 AC: 503AN: 1461802Hom.: 0 Cov.: 31 AF XY: 0.000316 AC XY: 230AN XY: 727214
GnomAD4 exome
AF:
AC:
503
AN:
1461802
Hom.:
Cov.:
31
AF XY:
AC XY:
230
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000237 AC: 36AN: 151832Hom.: 0 Cov.: 32 AF XY: 0.000243 AC XY: 18AN XY: 74192
GnomAD4 genome
AF:
AC:
36
AN:
151832
Hom.:
Cov.:
32
AF XY:
AC XY:
18
AN XY:
74192
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
12
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.85C>T (p.R29C) alteration is located in exon 2 (coding exon 1) of the ASAH2B gene. This alteration results from a C to T substitution at nucleotide position 85, causing the arginine (R) at amino acid position 29 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;T
Sift4G
Benign
.;T
Polyphen
D;D
Vest4
0.33
MVP
0.42
MPC
0.54
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at